Feng Mao

Featured in: Favicon

nature.com Favicon

sciencedirect.com Favicon

hindawi.com Favicon

warwick.ac.uk Favicon

acpjournals.org Favicon

dovepress.com + 3 more

Articles

Different treatment durations of loperamide in preventing pyrotinib-induced diarrhea: A randomized, parallel-group sub-study of the phase II PHAEDRA trial

Aug 20, 2024 | medrxiv.org | Changjun Wang |Yan Lin |Ying Xu |Feng Mao

The authors have declared no competing interest. NCT04659499The study drugs pyrotinib and nab-paclitaxel were provided by Jiangsu Hengrui Pharmaceuticals Co., Ltd. This study was funded by the National High-Level Hospital Clinical Research Funding (No. 2022-PUMCH-B-038 and No. 2022-PUMCH-C-066) and TSC China Allicace (#LAM001-202205). I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →